Literature DB >> 11387326

Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence.

O Goldshmidt1, E Zcharia, H Aingorn, Z Guatta-Rangini, R Atzmon, I Michal, I Pecker, E Mitrani, I Vlodavsky.   

Abstract

Cleavage of heparan sulfate (HS) proteoglycans affects the integrity and function of tissues and thereby fundamental phenomena, involving cell migration and response to changes in the extracellular microenvironment. The role of HS-degrading enzymes, commonly referred to as heparanases, in normal development has not been identified. The present study focuses on cloning, expression, and properties of a chicken heparanase and its distribution in the developing chicken embryo. We have identified a chicken EST, homologous to the recently cloned human heparanase, to clone and express a functional chicken heparanase, 60% homologous to the human enzyme. The full-length chicken heparanase cDNA encodes a 60-kDa proenzyme that is processed at the N terminus into a 45-kDa highly active enzyme. The most prominent difference between the chicken and human enzymes resides in the predicted signal peptide sequence, apparently accounting for the chicken heparanase being readily secreted and localized in close proximity to the cell surface. In contrast, the human enzyme is mostly intracellular, localized in perinuclear granules. Cells transfected with a chimeric construct composed of the chicken signal peptide preceding the human heparanase exhibited cell surface localization and secretion of heparanase, similar to cells transfected with the full-length chicken enzyme. We examined the distribution pattern of the heparanase enzyme in the developing chicken embryo. Both the chicken heparanase mRNA and protein were expressed, as early as 12 h post fertilization, in cells migrating from the epiblast and forming the hypoblast layer. Later on (72 h), the enzyme is preferentially expressed in cells of the developing vascular and nervous systems. Cloning and characterization of heparanase, the first and single functional vertebrate HS-degrading enzyme, may lead to identification of other glycosaminoglycan degrading enzymes, toward elucidation of their significance in normal and pathological processes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11387326     DOI: 10.1074/jbc.M102462200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

Authors:  I Vlodavsky; Y Friedmann
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Expression of heparanase in vascular cells and astrocytes of the mouse brain after focal cerebral ischemia.

Authors:  Jimei Li; Jin-Ping Li; Xiao Zhang; Zhongyang Lu; Shan Ping Yu; Ling Wei
Journal:  Brain Res       Date:  2011-11-19       Impact factor: 3.252

3.  Cloning, expression, and characterization of an alternatively spliced variant of human heparanase.

Authors:  Nicola J Nasser; Aaron Avivi; Moran Shushy; Israel Vlodavsky; Eviatar Nevo
Journal:  Biochem Biophys Res Commun       Date:  2007-01-02       Impact factor: 3.575

4.  Adaptive evolution of heparanase in hypoxia-tolerant Spalax: gene cloning and identification of a unique splice variant.

Authors:  Nicola J Nasser; Eviatar Nevo; Itay Shafat; Neta Ilan; Israel Vlodavsky; Aaron Avivi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-04       Impact factor: 11.205

5.  The role of heparanase in lymph node metastatic dissemination: dynamic contrast-enhanced MRI of Eb lymphoma in mice.

Authors:  Hagit Dafni; Batya Cohen; Keren Ziv; Tomer Israely; Orit Goldshmidt; Nava Nevo; Alon Harmelin; Israel Vlodavsky; Michal Neeman
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

6.  Transgenic over-expression of mammalian heparanase delays prion disease onset and progression.

Authors:  O Kovalchuk Ben-Zaken; I Nissan; S Tzaban; A Taraboulos; E Zcharia; S Matzger; I Shafat; I Vlodavsky; Y Tal
Journal:  Biochem Biophys Res Commun       Date:  2015-07-10       Impact factor: 3.575

7.  Role of endothelial heparanase in delayed-type hypersensitivity.

Authors:  Evgeny Edovitsky; Immanuel Lerner; Eyal Zcharia; Tamar Peretz; Israel Vlodavsky; Michael Elkin
Journal:  Blood       Date:  2005-12-29       Impact factor: 22.113

8.  Glycosaminoglycans from chicken muscular stomach or gizzard.

Authors:  Yin Chen; Megan Reddy; Yanlei Yu; Fuming Zhang; Robert J Linhardt
Journal:  Glycoconj J       Date:  2016-10-17       Impact factor: 2.916

9.  Low and high affinity receptors mediate cellular uptake of heparanase.

Authors:  Olga Ben-Zaken; Itay Shafat; Svetlana Gingis-Velitski; Haim Bangio; Idil Kasuto Kelson; Tal Alergand; Yehudit Amor; Ruth Ben-Yakar Maya; Israel Vlodavsky; Neta Ilan
Journal:  Int J Biochem Cell Biol       Date:  2007-09-29       Impact factor: 5.085

10.  Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis.

Authors:  Orit Goldshmidt; Eyal Zcharia; Rinat Abramovitch; Shula Metzger; Helena Aingorn; Yael Friedmann; Volker Schirrmacher; Eduardo Mitrani; Israel Vlodavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.